Diane-35 was never introduced in any form in the United States due to concerns over its risk of causing blood clots. The formulation of Diane contains cyproterone acetate, which is an antiandrogen and can increase the risk of venous thromboembolism (VTE), especially when compared to other contraceptive pills available in the US.